Kathryn Lang, vice president of Health Outcomes and Evidence at Guardant Health discusses research highlighting the significance of its LUNAR-2 liquid b...
Steve Tilles, Senior Director of Medical Affairs at Aimmune Therapeutics, the first company to gain FDA approval of a peanut allergy treatment, PALFORZI...
Susan Mitmesser, VP of Science and Technology at Pharmavite, makers of Nature Made vitamins and supplements, discusses a review paper by Pharmavite that...
Daniel Simon discusses the GuardantINFORM™ platform featuring an extensive clinical-genomic liquid biopsy dataset of advanced cancer patients.
Galderma's "Beyond the visible: rosacea and psoriasis of the face" is a global survey involving over 600 patients with facial skin disease (rosacea or p...
Carlos Doti discusses the results from two trials - Ph.2 ACE-CL-001 and Ph.3 ASCEND, that was presented at the virtual edition of the European Hematolog...
Imamu Tomlinson, CEO of Vituity and a practicing emergency physician, discusses his own experience with discrimination as a Black American and how it ha...
Linda Hand, CEO of Prealize, discusses the use of AI and machine learning to pinpoint individuals and populations most likely to have a significant heal...
Cedric Bryant, Ph.D., Chief Science Officer at the American Council on Exercise (ACE) discusses ACE's behavior change research-based philosophy called t...
Roy Herbst, MD, of Yale Cancer Center and Smilow Cancer Hospital, discusses data presented at the American Society of Clinical Oncology (ASCO20) Virtual...